Neuromuscular Blockers: Botox, Daxxify, Dysport, Myobloc, and Xeomin
Customize your policy alerts
Sign up for all Mass General Brigham Health Plan policy alerts
Know when Mass General Brigham Health Plan releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs MassHealth prior authorization for Botox, Daxxify, Dysport, Myobloc, and Xeomin under the medical benefit, including covered indications, dose limits, prescriber requirements, prerequisite therapies, and continuation criteria. The medications are also available under the pharmacy benefit and require review under the applicable MassHealth pharmacy policy.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.